Partillion Bioscience offers the Pilot-to-Grant Program, which provides Nanovial reagents to researchers for generating pilot data for grant submissions.
Public source
Publisher name
Public post
Its September and fall grant deadlines are fast approaching. Do you need pilot data to strengthen your proposal? Partillion’s Pilot-to-Grant Program provides eligible re…
Company
Partillion Bioscience
Biology Emerges Between Cells
- Industry
- Biotechnology
- Location
- Los Angeles, US
- Company size
- 11–50 employees
About Partillion Bioscience
Partillion Bioscience is pioneering functional cell analysis with its award-winning Nanovial technology. Our platform enables pharmaceutical and biotech partners to screen millions of live cells in parallel and identify cells based on what they do, including secretion, signaling, and viability. Partillion’s technology has been featured in leading scientific journals and recognized with multiple industry awards, including the 2025 CYTO Innovation & Technology Showcase Award.
See moreLatest activity
Latest activity from Partillion Bioscience
2 signals
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
Palleon Pharmaceuticals
Palleon Pharmaceuticals created the Glycobiology Education Hub, a curated collection of essential reading, key scientific literature, Palleon publications, and educational videos.
Products & Services
EditCo Bio
EditCo Bio offers Arrayed Screening Libraries as part of a limited-time offer.
Products & Services
BioIVT
BioIVT launched a new Voluntary Data Submission pilot allowing companies, method developers, CROs, academic laboratories, consortia, and other stakeholders to submit and discuss NAM data independently of a Marketing Authorisation Application.
Products & Services
University Lab Partners
University Lab Partners launched its Fall Courses offering featuring molecular biology, bio-innovators, cancer research, and the MIRE Program.
Products & Services
Synbio Technologies